Companies / Callan JMB Inc

Callan JMB Inc

Nasdaq: CJMBCIK 2032545SPRING BRANCH, TX

Financials · FY2025

Revenue$5.72M
Net income$-7.97M
Total debt$0
Cash$1.42M
Diluted EPS$-1.82
Shares outstanding5.6M

Ownership

5.6M shares outstanding · as of May 14, 2026
14.2%Insiders
Ownership
Insiders14.20%802,000
10%+ / strategic4.35%245,682
Institutions8.19%462,527
Public float73.25%4,135,909

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider% of sharesShares
Croyle David JChief Medical Officer · 10% owner
14.17%800,000
Dial GeraldDirector
0.04%2,000

Institutional holders 12

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 6, 2026Croyle David J
Executive
BuyCommon Stock$26.1K+15K
+1.91%
789,805
13.99% of shares
low
Mar 20, 2026Croyle David J
Executive
BuyCommon Stock$17.8K+10K
+1.29%
800,000
14.17% of shares
low
Dec 30, 2025Dial Gerald
Director
BuyCommon Stock$1.8K+2K
+333.84%
2,000
0.04% of shares
low
Dec 30, 2025Dial Gerald
Director
BuyCommon Stock$562+461
461
<0.01% of shares
low
Feb 4, 2025Dial Gerald
Director
GrantOption (Right to Buy)—+25K
25,000
0.44% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Bard Associates, Inc.Passive13G/A—245,682—
Bard Associates, Inc.Passive13G/A—239,266—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CJMB——131100109—